These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19101143)

  • 1. Discovery and optimization of imidazo[1,2-a]pyridine inhibitors of insulin-like growth factor-1 receptor (IGF-1R).
    Emmitte KA; Wilson BJ; Baum EW; Emerson HK; Kuntz KW; Nailor KE; Salovich JM; Smith SC; Cheung M; Gerding RM; Stevens KL; Uehling DE; Mook RA; Moorthy GS; Dickerson SH; Hassell AM; Leesnitzer MA; Shewchuk LM; Groy A; Rowand JL; Anderson K; Atkins CL; Yang J; Sabbatini P; Kumar R
    Bioorg Med Chem Lett; 2009 Feb; 19(3):1004-8. PubMed ID: 19101143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel imidazo[1,2-a]pyridine based inhibitors of the IGF-1 receptor tyrosine kinase: optimization of the aniline.
    Ducray R; Jones CD; Jung FH; Simpson I; Curwen J; Pass M
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4702-4. PubMed ID: 21764307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel imidazo[1,2-a]pyridines as inhibitors of the insulin-like growth factor-1 receptor tyrosine kinase.
    Ducray R; Simpson I; Jung FH; Nissink JW; Kenny PW; Fitzek M; Walker GE; Ward LT; Hudson K
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4698-701. PubMed ID: 21775140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of 3,5-disubstituted-1H-pyrrolo[2,3-b]pyridines as potent inhibitors of the insulin-like growth factor-1 receptor (IGF-1R) tyrosine kinase.
    Patnaik S; Stevens KL; Gerding R; Deanda F; Shotwell JB; Tang J; Hamajima T; Nakamura H; Leesnitzer MA; Hassell AM; Shewchuck LM; Kumar R; Lei H; Chamberlain SD
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3136-40. PubMed ID: 19394223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a (1H-benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) inhibitor of insulin-like growth factor I receptor kinase with in vivo antitumor activity.
    Wittman M; Carboni J; Attar R; Balasubramanian B; Balimane P; Brassil P; Beaulieu F; Chang C; Clarke W; Dell J; Eummer J; Frennesson D; Gottardis M; Greer A; Hansel S; Hurlburt W; Jacobson B; Krishnananthan S; Lee FY; Li A; Lin TA; Liu P; Ouellet C; Sang X; Saulnier MG; Stoffan K; Sun Y; Velaparthi U; Wong H; Yang Z; Zimmermann K; Zoeckler M; Vyas D
    J Med Chem; 2005 Sep; 48(18):5639-43. PubMed ID: 16134929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and initial SAR of 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as inhibitors of insulin-like growth factor 1-receptor (IGF-1R).
    Velaparthi U; Wittman M; Liu P; Stoffan K; Zimmermann K; Sang X; Carboni J; Li A; Attar R; Gottardis M; Greer A; Chang CY; Jacobsen BL; Sack JS; Sun Y; Langley DR; Balasubramanian B; Vyas D
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2317-21. PubMed ID: 17317169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and SAR of thiazolidine-2,4-dione analogues as insulin-like growth factor-1 receptor (IGF-1R) inhibitors via hierarchical virtual screening.
    Liu X; Xie H; Luo C; Tong L; Wang Y; Peng T; Ding J; Jiang H; Li H
    J Med Chem; 2010 Mar; 53(6):2661-5. PubMed ID: 20178321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of an inhibitor of insulin-like growth factor 1 receptor activation: implications for cellular potency and selectivity over insulin receptor.
    Wood ER; Shewchuk L; Hassel A; Nichols J; Truesdale AT; Smith D; Carter HL; Weaver K; Barrett G; Leesnitzer T; Alvarez E; Bardera AI; Alamillo A; Cantizani J; Martin J; Smith GK; Jensen DE; Xie H; Mook R; Kumar R; Kuntz K
    Biochem Pharmacol; 2009 Dec; 78(12):1438-47. PubMed ID: 19665448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a Potent, Selective, Orally Bioavailable, and Efficacious Novel 2-(Pyrazol-4-ylamino)-pyrimidine Inhibitor of the Insulin-like Growth Factor-1 Receptor (IGF-1R).
    Degorce SL; Boyd S; Curwen JO; Ducray R; Halsall CT; Jones CD; Lach F; Lenz EM; Pass M; Pass S; Trigwell C
    J Med Chem; 2016 May; 59(10):4859-66. PubMed ID: 27078757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The discovery of biaryl carboxamides as novel small molecule agonists of the motilin receptor.
    Westaway SM; Brown SL; Conway E; Heightman TD; Johnson CN; Lapsley K; Macdonald GJ; MacPherson DT; Mitchell DJ; Myatt JW; Seal JT; Stanway SJ; Stemp G; Thompson M; Celestini P; Colombo A; Consonni A; Gagliardi S; Riccaboni M; Ronzoni S; Briggs MA; Matthews KL; Stevens AJ; Bolton VJ; Boyfield I; Jarvie EM; Stratton SC; Sanger GJ
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6429-36. PubMed ID: 19006669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SAR of PXR transactivation in benzimidazole-based IGF-1R kinase inhibitors.
    Zimmermann K; Wittman MD; Saulnier MG; Velaparthi U; Sang X; Frennesson DB; Struzynski C; Seitz SP; He L; Carboni JM; Li A; Greer AF; Gottardis M; Attar RM; Yang Z; Balimane P; Discenza LN; Lee FY; Sinz M; Kim S; Vyas D
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1744-8. PubMed ID: 20153189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and structural characterization of a novel class of inhibitors of the type 1 insulin-like growth factor and insulin receptor kinases.
    Bell IM; Stirdivant SM; Ahern J; Culberson JC; Darke PL; Dinsmore CJ; Drakas RA; Gallicchio SN; Graham SL; Heimbrook DC; Hall DL; Hua J; Kett NR; Kim AS; Kornienko M; Kuo LC; Munshi SK; Quigley AG; Reid JC; Trotter BW; Waxman LH; Williams TM; Zartman CB
    Biochemistry; 2005 Jul; 44(27):9430-40. PubMed ID: 15996097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lead optimization of 5,6-diarylpyridines as CB1 receptor inverse agonists.
    Madsen-Duggan CB; Debenham JS; Walsh TF; Toupence RB; Huang SX; Wang J; Tong X; Lao J; Fong TM; Schaeffer MT; Xiao JC; Huang CR; Shen CP; Stribling DS; Shearman LP; Strack AM; MacIntyre DE; Van der Ploeg LH; Goulet MT
    Bioorg Med Chem Lett; 2007 Apr; 17(7):2031-5. PubMed ID: 17270441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of a series of meta aniline-based LFA-1 ICAM inhibitors.
    Guckian KM; Lin EY; Silvian L; Friedman JE; Chin D; Scott DM
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5249-51. PubMed ID: 18778938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imidazoles: SAR and development of a potent class of cyclin-dependent kinase inhibitors.
    Anderson M; Andrews DM; Barker AJ; Brassington CA; Breed J; Byth KF; Culshaw JD; Finlay MR; Fisher E; McMiken HH; Green CP; Heaton DW; Nash IA; Newcombe NJ; Oakes SE; Pauptit RA; Roberts A; Stanway JJ; Thomas AP; Tucker JA; Walker M; Weir HM
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5487-92. PubMed ID: 18815031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminopiperidine-fused imidazoles as dipeptidyl peptidase-IV inhibitors.
    Edmondson SD; Mastracchio A; Cox JM; Eiermann GJ; He H; Lyons KA; Patel RA; Patel SB; Petrov A; Scapin G; Wu JK; Xu S; Zhu B; Thornberry NA; Roy RS; Weber AE
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4097-101. PubMed ID: 19539471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a 2,4-disubstituted pyrrolo[1,2-f][1,2,4]triazine inhibitor (BMS-754807) of insulin-like growth factor receptor (IGF-1R) kinase in clinical development.
    Wittman MD; Carboni JM; Yang Z; Lee FY; Antman M; Attar R; Balimane P; Chang C; Chen C; Discenza L; Frennesson D; Gottardis MM; Greer A; Hurlburt W; Johnson W; Langley DR; Li A; Li J; Liu P; Mastalerz H; Mathur A; Menard K; Patel K; Sack J; Sang X; Saulnier M; Smith D; Stefanski K; Trainor G; Velaparthi U; Zhang G; Zimmermann K; Vyas DM
    J Med Chem; 2009 Dec; 52(23):7360-3. PubMed ID: 19778024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,5-Disubstituted pyridines: the discovery of a novel series of 5-HT2A ligands.
    Wilson KJ; van Niel MB; Cooper L; Bloomfield D; O'Connor D; Fish LR; MacLeod AM
    Bioorg Med Chem Lett; 2007 May; 17(9):2643-8. PubMed ID: 17314044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of 2'-anilino-4,4'-bipyridines as selective inhibitors of c-Jun N-terminal kinase-3.
    Swahn BM; Xue Y; Arzel E; Kallin E; Magnus A; Plobeck N; Viklund J
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1397-401. PubMed ID: 16337120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent and selective cyclohexyl-derived imidazopyrazine insulin-like growth factor 1 receptor inhibitors with in vivo efficacy.
    Jin M; Kleinberg A; Cooke A; Gokhale PC; Foreman K; Dong H; Siu KW; Bittner MA; Mulvihill KM; Yao Y; Landfair D; O'Connor M; Mak G; Pachter JA; Wild R; Rosenfeld-Franklin M; Ji Q; Mulvihill MJ
    Bioorg Med Chem Lett; 2011 Feb; 21(4):1176-80. PubMed ID: 21251824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.